2BB score and signals
Sagimet Biosciences Inc.’s current 2BB score is 35 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 39 | Low |
| Momentum | 66 | Improving |
| Financial strength | 32 | Weak |
| Quality | 37 | Weak |
| Risk | 47 | Moderate |
Company facts
| Headquarters | San Mateo, California, United States |
| Founded | 2006 |
| Employees | 16 |
| 52-week range | $4.50 – $11.45 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-16 | — | -0.2675 | — | $0.00 |
| 2026-08-19 | — | -0.2511 | — | $0.00 |
| 2026-05-12 | -0.33 | -0.3818 | $0.00 | $0.00 |
| 2026-03-11 | -0.29 | -0.4149 | $0.00 | $0.00 |
Related companies
